ClinicalTrials.govpublic full text
MRD Response-adapted Allo-HSCT for Adverse-risk AML
acute myeloid leukemia, allogeneic hematopoietic stem cell transplantation, measurable residual disease, adverse risk, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800228
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.